Amantadine therapy for chronic hepatitis CA randomized double-blind placebo-controlled trial

被引：0
作者：
Jill P. Smith
Thomas R. Riley
Attila Devenyi
Sandra I. Bingaman
Allen Kunselman
机构：
[1] Pennsylvania State College of Medicine,Department of Medicine
[2] The Milton S. Hershey Medical Center,Department of Pediatrics
[3] Pennsylvania State College of Medicine,Department of Health Evaluation Sciences
[4] The Milton S. Hershey Medical Center,Division of Gastroenterology and Hepatology
[5] Pennsylvania State College of Medicine,undefined
[6] The Milton S. Hershey Medical Center,undefined
[7] Pennsylvania State University,undefined
[8] Milton S. Hershey Medical Center,undefined
来源：
Journal of General Internal Medicine | 2004年 / 19卷
关键词：
amantadine; liver; virus; cirrhosis; interferon;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
OBJECTIVE: Although treatment of hepatitis C has improved, up to 50% do not respond to standard therapy with interferon regimes or cannot tolerate the treatment due to side effects. The purpose of the present investigation was to evaluate the safety and effectiveness of the antiviral drug amantadine for the treatment of hepatitis C in those who had either previously failed interferon therapy or were not candidates for interferon.
引用
收藏
页码：662 / 668
页数：6
相关论文
共 86 条
[1]  
Laurence SP(2000)Advances in the treatment of hepatitis C Adv Intern Med 45 65-105
[2]  
Glue P(2000)A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C Hepatology 32 647-53
[3]  
Rouzier-Pamis R(2002)Optimal therapy of hepatitis C Hepatology 36 S121-S127
[4]  
Raffanel C(1993)Prediction of the response of chronic hepatitis C to interferon alfa: a statistical analysis of pretreatment variables Gut 34 1714-7
[5]  
DiBisceglie AM(2000)Genotype and viral load as prognostic indicators in the treatment of hepatitis C J Viral Hepat 7 250-7
[6]  
Hoofnagle JH(1994)Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis Gastroenterology 106 686-90
[7]  
Camps J(2000)The significance of baseline serum alanine aminotransferase on pretreatment disease characteristics and response to antiviral therapy in chronic hepatitis C Hepatology 32 400-4
[8]  
Crisostomo S(1999)Chronic hepatitis C viral infection in patients with normal serum alanine aminotransferases Am J Med 107 535-55
[9]  
Garcia-Granero M(1999)Management of interferon relapsers Am J Med 107 625-65
[10]  
Riezu-Boj JI(2003)Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin Hepatology 38 66-74
123456789